Cargando…
An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine
Autores principales: | Mitra, Raman L., Greenstein, Steven A., Epstein, Laurence M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195299/ https://www.ncbi.nlm.nih.gov/pubmed/32363145 http://dx.doi.org/10.1016/j.hrcr.2020.03.016 |
Ejemplares similares
-
Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine
por: Sarayani, Amir, et al.
Publicado: (2021) -
QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020) -
QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin
por: Hsia, Brian C, et al.
Publicado: (2020) -
Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020) -
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19
por: O’Connell, Thomas F., et al.
Publicado: (2021)